Pharmaceutical Analysis

Latest News

AstraZeneca Bets Big on U.S. Growth with $50 Billion Investment in R&D and Production
AstraZeneca Bets Big on U.S. Growth with $50 Billion Investment in R&D and Production

July 23rd 2025

A multi-billion-dollar drug manufacturing hub focused on chronic diseases will be established in Virginia, supported by new facilities across California, Indiana, Maryland, Massachusetts, and Texas.

Top view of vibrant pink and blue pharmaceutical capsules and tablets with granular textures under soft lighting ideal for cosmetics-based healthcare branding and product visuals. Generated with AI. | Image Credit: © gleb - stock.adobe.com.
New Correction Technique Enhances Accuracy of Transmission Raman Spectroscopy in Pharmaceutical Quality Testing

July 23rd 2025

Big Pharma's Manufacturing Shift Could Provide New Opportunities for Chemists
Big Pharma's Manufacturing Shift Could Provide New Opportunities for Chemists

July 23rd 2025

Professional Pet Doctor Utilizing Digital Technology for Animal Diagnosis and Veterinary Services. Generated with AI. | Image Credit: © Your_Demon - stock.adobe.com
New Ecofriendly Spectrophotometric Method Boosts Accuracy in Veterinary Drug Analysis

June 30th 2025

White pills laid out on a network of connections representing medical technology and pharmaceutical research | Image Credit: © ylivdesign - stock.adobe.com
AI-Powered Raman Spectroscopy Signals New Era for Drug Development and Disease Diagnosis

June 4th 2025

More News

ICP-MS Speciation Analysis: Three Roles of Selenium

ICP-MS Speciation Analysis: Three Roles of Selenium

Katie DeNicola Cafferky;Joseph A. Caruso;Douglas D. Richardson
February 1st 2006

The element selenium plays three distinct roles in biological processes, functioning in turn as a toxicant, a chemopreventive agent, and a heavy metal antagonist. This article discusses current research associated with each role, and how ICP-MS can be employed to better understand and utilize selenium's properties.

<123